Feb 17 (Reuters) - Memphasys Ltd (MEM)
- Provides following details and a summary of dispute resolution process it has commenced
- Prime Biologics Pte Ltd ("Prime") and Memphasys Ltd have agreed by mutual consent in legal proceedings in Nsw Supreme Court
- Now filed an application for arbitration in Singapore to hear and resolve dispute between Memphasys, Prime Biologics and Manukan
- Arbitration will primarily deal with s$4.8 million debt associated with fit-out of rental facility that prime is using in singapore
- Memphasys remains optimistic that a positive outcome from arbitration process will be achieved
